New York State Common Retirement Fund
ORKA

New York State Common Retirement Fund’s Oruka Therapeutics ORKA Stock Holding History

New York State Common Retirement Fund’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
17,700
+5,500
+45% +$366K ﹤0.01% 1534
2026
Q1 		$598K Buy
12,200
+3,600
+42% +$125K ﹤0.01% 1844
2025
Q4 		$261K Hold
8,600
– – ﹤0.01% 2178
2025
Q3 		$165K Hold
8,600
– – ﹤0.01% 2384
2025
Q2 		$96.4K Buy
+8,600
New +$89.6K ﹤0.01% 2701

Other funds holding ORKA

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

New York State Common Retirement Fund's ORKA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Oruka Therapeutics (ORKA) stake by 45% in Q2 2026, buying an estimated $366K and bringing the position to 17,700 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

New York State Common Retirement Fund first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 53 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • New York State Common Retirement Fund held 17,700 shares of Oruka Therapeutics worth $1.68M as of Q2 2026.
  • New York State Common Retirement Fund bought 5,500 Oruka Therapeutics shares in Q2 2026, an estimated $366K.
  • Oruka Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1534 holding.
  • New York State Common Retirement Fund first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 53 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.